 BHCs stake in BLCO that is set to be distributed to shareholders is worth more than the current market capitalization of the entirety of BHC, giving investors a compelling return. The BLCO spinoff and Solta Medical IPO proceeds are sufficient for BHC to shoulder its approximately 20 billion debt load. 